Joy Behar revealed on the Feb. 18 episode of The View that she lost 25 pounds using a GLP-1 drug—and she wasn't the only ...

Study finds weight loss results drive continued Ozempic use despite nausea and other side effects, based on real world ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: You can get semaglutide injections (Ozempic® and Wegovy®) and oral semaglutide (Rybelsus®). Injections are usually more ...

Patients who use semaglutide for weight loss, like Ozempic, are more likely to continue the medication if they perceive it as ...

According to recent data, patients initiating semaglutide had a substantially greater risk of developing NAION versus those starting SGLT2 inhibitors. Although rare, semaglutide initiation can lead to ...

An experimental combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to late-stage trial data.

Novo Nordisk, the manufacturer of Wegovy, responded strongly to the initial launch of Hims & Hers’ compounded semaglutide ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist … ...

We read with interest the Article by Marc P Bonaca and colleagues, which showed that the GLP-1 receptor agonist semaglutide improves walking distance by 13% in patients with peripheral artery disease ...

By Anusha Shah and Amina Niasse Feb 7 (Reuters) - Online telehealth company Hims & Hers on Saturday reversed course on its ...

With the recommendation of using Wegovy, a semaglutide medication, your doctor is following new data on reducing cardiovascular risk. New research has found that these medications can improve the ...

The success of weight-loss drugs has driven demand for injectable compounds that claim to improve everything from sleep to skin.